---
title: "RVMD SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for Revolution Medicines (RVMD), with links to the SEC filings."
url: "https://tradytics.com/research/RVMD/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=RVMD&v=stock-11994868"
---

# RVMD financial statements and SEC filings

## RVMD annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $0.00 | -$1.18B | -$1.13B | [10-K](https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/0001193125-26-071563-index.htm) |
| 2024-12-31 | $0.00 | -$689.52M | -$600.09M | [10-K](https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/0001193125-26-071563-index.htm) |
| 2023-12-31 | $11.58M | -$487.19M | -$436.37M | [10-K](https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/0001193125-26-071563-index.htm) |
| 2022-12-31 | $35.38M | -$258.28M | -$248.71M | [10-K](https://www.sec.gov/Archives/edgar/data/1628171/000095017025027736/0000950170-25-027736-index.htm) |
| 2021-12-31 | $29.39M | -$188.01M | -$187.09M | [10-K](https://www.sec.gov/Archives/edgar/data/1628171/000095017024020145/0000950170-24-020145-index.htm) |
| 2020-12-31 | $42.98M | -$110.70M | -$110.38M | [10-K](https://www.sec.gov/Archives/edgar/data/1628171/000095017023004645/0000950170-23-004645-index.htm) |

## RVMD annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $2.35B | $723.21M | $1.63B | [10-Q](https://www.sec.gov/Archives/edgar/data/1628171/000119312526447253/0001193125-26-447253-index.htm) |
| 2024-12-31 | $2.56B | $293.10M | $2.27B | [10-K](https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/0001193125-26-071563-index.htm) |
| 2023-12-31 | $2.06B | $235.51M | $1.83B | [10-K](https://www.sec.gov/Archives/edgar/data/1628171/000095017025027736/0000950170-25-027736-index.htm) |
| 2022-12-31 | $811.93M | $126.74M | $685.19M | [10-K](https://www.sec.gov/Archives/edgar/data/1628171/000095017024020145/0000950170-24-020145-index.htm) |
| 2021-12-31 | $737.99M | $135.42M | $602.57M | [10-K](https://www.sec.gov/Archives/edgar/data/1628171/000095017023004645/0000950170-23-004645-index.htm) |
| 2020-12-31 | $567.40M | $92.72M | $474.68M | [10-K](https://www.sec.gov/Archives/edgar/data/1628171/000095017022002297/0000950170-22-002297-index.htm) |

## RVMD annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | -$897.74M | -$15.99M | $621.52M | [10-K](https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/0001193125-26-071563-index.htm) |
| 2024-12-31 | -$557.44M | -$10.31M | $959.41M | [10-K](https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/0001193125-26-071563-index.htm) |
| 2023-12-31 | -$350.57M | -$7.73M | $1.23B | [10-K](https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/0001193125-26-071563-index.htm) |
| 2022-12-31 | -$224.40M | -$10.82M | $301.43M | [10-K](https://www.sec.gov/Archives/edgar/data/1628171/000095017025027736/0000950170-25-027736-index.htm) |
| 2021-12-31 | -$147.18M | -$6.53M | $294.18M | [10-K](https://www.sec.gov/Archives/edgar/data/1628171/000095017024020145/0000950170-24-020145-index.htm) |
| 2020-12-31 | -$100.06M | -$2.93M | $422.78M | [10-K](https://www.sec.gov/Archives/edgar/data/1628171/000095017023004645/0000950170-23-004645-index.htm) |

- [RVMD stock research](https://tradytics.com/research/RVMD)
- [RVMD financial summary](https://tradytics.com/research/RVMD/financials)
- [Read the data without JavaScript](https://tradytics.com/research/RVMD/fundamentals?snapshot=1)
